Ad-HPV E6/E7 vaccine (VectorLogics)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameAd-HPV E6/E7 vaccine (VectorLogics)

Drug Alias Nameadenoviral HPV E6/E7 vaccine (VectorLogics)cervical cancer vaccine (VectorLogics)dual CD40 costimulator/HPV E6 and HPV E7 antigens (adenoviral vector vaccine) (VectorLogics)endritic cell-targeted vaccine (VectorLogics)

ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Recombinant vector vaccine

Mechanisms of ActionTumor necrosis factor receptor superfamily member 5 agonistsUbiquitin-like modifier-activating enzyme 3A modulators

TargetsUbiquitin-like modifier-activating enzyme 3ATumor necrosis factor receptor superfamily member 5

Therapy Area/IndicationsUterine Cervical Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesVectorlogics

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesVectorlogics

Active IndicationsN/A

Inactive IndicationsUterine Cervical Neoplasms

Other Information

ATC CodeN/A